These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 32379199)
1. A Case of Critically Ill Infant of Coronavirus Disease 2019 With Persistent Reduction of T Lymphocytes. Qiu L; Jiao R; Zhang A; Chen X; Ning Q; Fang F; Zeng F; Tian N; Zhang Y; Huang Y; Sun Z; Dhuromsingh M; Li H; Li Y; Xu R; Chen Y; Luo X Pediatr Infect Dis J; 2020 Jul; 39(7):e87-e90. PubMed ID: 32379199 [TBL] [Abstract][Full Text] [Related]
2. Clinical Characteristics and Immune Injury Mechanisms in 71 Patients with COVID-19. Wu Y; Huang X; Sun J; Xie T; Lei Y; Muhammad J; Li X; Zeng X; Zhou F; Qin H; Shao L; Zhang Q mSphere; 2020 Jul; 5(4):. PubMed ID: 32669467 [TBL] [Abstract][Full Text] [Related]
3. Clinical Analysis of 25 COVID-19 Infections in Children. Bai K; Liu W; Liu C; Fu Y; Hu J; Qin Y; Zhang Q; Chen H; Xu F; Li C Pediatr Infect Dis J; 2020 Jul; 39(7):e100-e103. PubMed ID: 32520888 [TBL] [Abstract][Full Text] [Related]
4. Lopinavir/ritonavir did not shorten the duration of SARS CoV-2 shedding in patients with mild pneumonia in Taiwan. Cheng CY; Lee YL; Chen CP; Lin YC; Liu CE; Liao CH; Cheng SH J Microbiol Immunol Infect; 2020 Jun; 53(3):488-492. PubMed ID: 32331982 [TBL] [Abstract][Full Text] [Related]
5. Clinical and Immune Features of Hospitalized Pediatric Patients With Coronavirus Disease 2019 (COVID-19) in Wuhan, China. Wu H; Zhu H; Yuan C; Yao C; Luo W; Shen X; Wang J; Shao J; Xiang Y JAMA Netw Open; 2020 Jun; 3(6):e2010895. PubMed ID: 32492165 [TBL] [Abstract][Full Text] [Related]
6. Acute SARS-CoV-2 Infection Impairs Dendritic Cell and T Cell Responses. Zhou R; To KK; Wong YC; Liu L; Zhou B; Li X; Huang H; Mo Y; Luk TY; Lau TT; Yeung P; Chan WM; Wu AK; Lung KC; Tsang OT; Leung WS; Hung IF; Yuen KY; Chen Z Immunity; 2020 Oct; 53(4):864-877.e5. PubMed ID: 32791036 [TBL] [Abstract][Full Text] [Related]
7. Risk factors for redetectable positivity in recovered COVID-19 children. Peng D; Zhang J; Ji Y; Pan D Pediatr Pulmonol; 2020 Dec; 55(12):3602-3609. PubMed ID: 33049115 [TBL] [Abstract][Full Text] [Related]
8. The Science Underlying COVID-19: Implications for the Cardiovascular System. Liu PP; Blet A; Smyth D; Li H Circulation; 2020 Jul; 142(1):68-78. PubMed ID: 32293910 [TBL] [Abstract][Full Text] [Related]
9. The laboratory tests and host immunity of COVID-19 patients with different severity of illness. Wang F; Hou H; Luo Y; Tang G; Wu S; Huang M; Liu W; Zhu Y; Lin Q; Mao L; Fang M; Zhang H; Sun Z JCI Insight; 2020 May; 5(10):. PubMed ID: 32324595 [TBL] [Abstract][Full Text] [Related]
10. Lopinavir/ritonavir for the treatment of SARS, MERS and COVID-19: a systematic review. Vargas M; Servillo G; Einav S Eur Rev Med Pharmacol Sci; 2020 Aug; 24(16):8592-8605. PubMed ID: 32894567 [TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 T cell immunity: Specificity, function, durability, and role in protection. Altmann DM; Boyton RJ Sci Immunol; 2020 Jul; 5(49):. PubMed ID: 32680954 [TBL] [Abstract][Full Text] [Related]
12. Factors associated with prolonged viral shedding and impact of lopinavir/ritonavir treatment in hospitalised non-critically ill patients with SARS-CoV-2 infection. Yan D; Liu XY; Zhu YN; Huang L; Dan BT; Zhang GJ; Gao YH Eur Respir J; 2020 Jul; 56(1):. PubMed ID: 32430428 [TBL] [Abstract][Full Text] [Related]
13. Viral kinetics and factors associated with rapid viral clearance during lopinavir/ritonavir-based combination therapy in non-severe COVID-19 patients. Ding JG; Li J; Hong L; Yu XQ; Ye EL; Sun GQ; Zhang XX; Chen L; Sun QF Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5788-5796. PubMed ID: 32495917 [TBL] [Abstract][Full Text] [Related]
14. Increased expression of CD8 marker on T-cells in COVID-19 patients. Ganji A; Farahani I; Khansarinejad B; Ghazavi A; Mosayebi G Blood Cells Mol Dis; 2020 Jul; 83():102437. PubMed ID: 32325421 [TBL] [Abstract][Full Text] [Related]
15. A report of clinical diagnosis and treatment of nine cases of coronavirus disease 2019. Chen Q; Quan B; Li X; Gao G; Zheng W; Zhang J; Zhang Z; Liu C; Li L; Wang C; Zhang G; Li J; Dai Y; Yang J; Han W J Med Virol; 2020 Jun; 92(6):683-687. PubMed ID: 32162699 [TBL] [Abstract][Full Text] [Related]
16. Clinical Characteristics and Factors Associated With Long-Term Viral Excretion in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection: a Single-Center 28-Day Study. Shi D; Wu W; Wang Q; Xu K; Xie J; Wu J; Lv L; Sheng J; Guo J; Wang K; Fang D; Li Y; Li L J Infect Dis; 2020 Aug; 222(6):910-918. PubMed ID: 32614392 [TBL] [Abstract][Full Text] [Related]
17. The Metabolic Changes and Immune Profiles in Patients With COVID-19. He B; Wang J; Wang Y; Zhao J; Huang J; Tian Y; Yang C; Zhang H; Zhang M; Gu L; Zhou X; Zhou J Front Immunol; 2020; 11():2075. PubMed ID: 32983157 [TBL] [Abstract][Full Text] [Related]
18. Positive SARS-CoV-2 RNA recurs repeatedly in a case recovered from COVID-19: dynamic results from 108 days of follow-up. Liu F; Cai ZB; Huang JS; Yu WY; Niu HY; Zhang Y; Sui DM; Wang F; Xue LZ; Xu AF Pathog Dis; 2020 Jun; 78(4):. PubMed ID: 32592396 [TBL] [Abstract][Full Text] [Related]
19. Immunological features of coronavirus disease 2019 in patients with cancer. Thibaudin M; Fumet JD; Bon M; Hampe L; Limagne E; Ghiringhelli F Eur J Cancer; 2020 Nov; 139():70-80. PubMed ID: 32977223 [TBL] [Abstract][Full Text] [Related]
20. Impaired Cytotoxic CD8 Westmeier J; Paniskaki K; Karaköse Z; Werner T; Sutter K; Dolff S; Overbeck M; Limmer A; Liu J; Zheng X; Brenner T; Berger MM; Witzke O; Trilling M; Lu M; Yang D; Babel N; Westhoff T; Dittmer U; Zelinskyy G mBio; 2020 Sep; 11(5):. PubMed ID: 32948688 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]